Senate Bill (PLS) No. 200, de 2015, analysis versus the Principle of the Prohibition of Social Regression

Abstract

The Senate Bill (PLS) number 200, of 2015, proposes the edition of a law for the conduction of clinical trials involving human subjects. This study aimed to perform a critical analysis of the PLS 200/2015, based on the Principle of the Prohibition of Social Regression. Thus, a descriptive, documentary and normative research was conducted, with survey of the ethical and sanitary standards related to clinical research and findings related to the PL 200/2015. The PLS 200/2015 and the information regarding was also consulted on the website of the Senate. The regulation of the matter by law demonstrated not to be a problem in the research. The main conflicts were related to the creation of Independent Ethics Committee (IEC), that does not link the ethic review to an State Agency; the use of placebo, in which flexibility is contrary to all efforts to ensure that participants have the best treatment options; and post-study access, which restriction is contrary to the existing regulations that determine the free and unlimited access. The analysis of the main settings specified in the PLS 200/2015 did not identify social or scientific improvements. The Principle of the Prohibition of Social Regression can be used, thus, to ensure the constitutional provisions already undertake and accomplished, mainly the right to health, human dignity and the inviolability of the right to live.